Author

Christiaan H. Arendzen

Leiden University Medical CenterORCID 0000-0002-0262-5288Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Aida Llucià ValldeperasiD· 1 shared Alexandre DeberiD· 1 shared Bharath K. SampadiiD· 1 shared Christian Freund· 1 shared Daniel Rubiera López· 1 shared Fjodor T. BekedamiD· 1 shared Frances S. de ManiD· 1 shared Francesc VenturaiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Aida Llucià ValldeperasORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Multi-omics reveals global signaling rewiring and identifies Activin A-induced dysregulation of FOS/Activator Protein 1 as a novel target in Fibrodysplasia ossificans progressiva

Marius Wits, Nerea Gomez-Suarez, Alexandre Deber, Nicole Farfán, Fjodor T. Bekedam, Bharath K. Sampadi, Sarah A. Rotman, Daniel Rubiera López, Judit Bestilleiro Márquez, Christiaan H. Arendzen, Christian Freund, Peter A. van Veelen, Aida Llucià Valldeperas, Frances S. de Man, Francesc Ventura, , Gonzalo Sánchez‐Duffhues

The paper uses multi-omics analyses to identify signaling dysregulation in FOP, highlighting AP-1 as a novel therapeutic target.

bioRxiv · Jan 21, 2025 · PreprintMolecular Biology